RxDoctor Payments Data

Stephen Hernandez, MD

Otolaryngology · Baton Rouge, LANPI 1487996187

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Acclarent, Inc at 38.6% of the total. Reporting peaked in 2022 at $1,673 and has fallen 52.1% since, to $801 in 2025.

$5,734in general payments, 2019–2025

Across 93 payments — averaging $61.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$2K
  • Medtronic$853
  • Integra Lifesciences Corporation$824
  • Stryker$361
  • Aerin Medical Inc.$279
  • Regeneron Healthcare Solutions, Inc.$210
  • plus $995 from 11 others

What the payments were for

  • Food & beverage$5,734100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,734 in reported general payments places this provider in the 85th percentile of 218 otolaryngology providers in Louisiana.

See all otolaryngology providers in Louisiana

Medicare billing

Part B allowed, 2024
$82,104
Medicare patients
118
Services billed
507

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab13$48,453
Ipratropium Bromide76$2,078
Mometasone Furoate18$1,340
Mupirocin19$438
Azelastine Hcl15$398
Fluticasone Propionate26$240
Doxycycline Monohydrate18$183
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$167
Levofloxacin24$108
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$44

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →